News Xbrane Biopharma Reports Resubmission of BLA to the US FDA for Ranibizumab Biosimilar Candidate ByDipanshu DixitDecember 31, 20240Comments
VIEWPOINTS GAIN JPAC 2024: Gerry Muhle from Galderma in a Stimulating Dialogue Exchange with PharmaShotsBySaurabh ChaubeyDecember 30, 20240Comments
News Johnson & Johnson Reports the EC’s Approval of Rybrevant (Amivantamab) Plus Lazcluze (Lazertinib) as a 1L Treatment of EGFRm NSCLC ByDipanshu DixitDecember 30, 20240Comments
News BMS’ Opdivo Qvantig SC Injection Secures the US FDA’s Approval for Solid Tumor Opdivo Indications ByDipanshu DixitDecember 27, 20240Comments
News BeiGene’s Tevimbra Plus Chemotherapy Secures the US FDA’s Approval as a 1L Treatment of G/GEJ Cancers ByDipanshu DixitDecember 26, 20240Comments
INSIGHTS+ Disease of the Month – Dry age-related macular degeneration (dAMD)ByDipanshu DixitDecember 24, 20240Comments
News Bio-Thera Solutions and Tabuk Pharmaceuticals Join Forces to Commercialize BAT2206 (Biosimilar, Stelara) in Saudi Arabia ByDipanshu DixitDecember 24, 20240Comments
VIEWPOINTS Fostering Safe AI Use: Jay Anders from Medicomp in a Riveting Conversation with PharmaShotsBySaurabh ChaubeyDecember 23, 20240Comments
News Novo Nordisk’s Alhemo Receives the US FDA’s Approval as a Prophylactic Treatment of Hemophilia A or B with Inhibitors ByDipanshu DixitDecember 20, 20240Comments
